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A b s t r a c t
Introduction: Despite successful repair of aortic coarctation, cardiovascular complications occur.
Aim: To analyse type and frequency of late complications and their impact on exercise capacity in adults after aortic coarctation repair.
Material and methods: Fifty-eight adults after aortic coarctation repair, 36 male, median age 27.46 ±10.57, were compared to 
30 healthy volunteers. Physical examination, transthoracic echocardiography, carotid intima-media thickness measurement, cardio-
pulmonary exercise test and 24-hour ambulatory blood pressure monitoring were performed.
Results: The main complications were: arterial hypertension 48.3%, myocardial hypertrophy in echocardiography 29.34%, re-
coarctation 25.86%, aortic dilation 13.79% and coronary artery disease 6.89%. Exercise tolerance was reduced in the cardiopulmo-
nary exercise test. The VO
2/kg peak was lower, 29.01 ±8.79 vs. 49.16 ±7.38 ml/kg/min, p < 0.001, VE/VCO2 peak higher 28.18 ±4.69 
vs. 26.78 ±3.13, p = 0.017. The peak heart rate was reduced, 157.28 ±22.22 vs. 177.93 ±23.08 bpm, p < 0.001, peak systolic blood 
pressure was higher, 174.79 ±17.62 vs. 153.33 ±4.79 mm Hg, p < 0.001. Systolic blood pressure in 24-hour ambulatory monitoring 
correlated with left ventricle mass index, r = 0.29, p = 0.025, wall thickness, r = 0.31, p = 0.039. Age at operation was related to left 
ventricle wall thickness, r = 0.27, p = 0.041, and carotid intima-media thickness, r = 0.26, p = 0.046. There was no association of any 
cardio-pulmonary parameters with time from surgery, type of operation or echocardiography results.
Conclusions: Adults after aortic coarctation repair suffer from arterial hypertension, recurrent aortic stenosis, aortic aneurysms, 
and coronary artery disease. Reduced exercise capacity in cardio-pulmonary exercise test is related to hypertensive reaction and 
chronotropic incompetence.
Key words: atherosclerosis risk factors, coarctation of aorta, exercise capacity, cardio-pulmonary exercise test, long-term com-
plications in coarctation of the aorta.
S u m m a r y
Despite successful repair of aortic coarctation, cardiovascular complications occur. The aim of this study was to analyse 
type and frequency of late complications and their impact on exercise capacity in adults after aortic coarctation repair. Adults 
after aortic coarctation repair suffer from arterial hypertension, recurrent aortic stenosis, aortic aneurysms, and coronary 
artery disease. Reduced exercise capacity in the cardio-pulmonary exercise test is related to hypertensive reaction and chro-
notropic incompetence.
Introduction
Coarctation of the aorta (CoA) is a congenital narrow-
ing of the descending aorta at the level of the subclavian 
artery [1]. It is the fifth most common congenital heart 
disorder with a prevalence from 5% to 9% of all congeni-
tal heart diseases [2] and 2 : 1 predominance in males [3]. 
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Aortic coarctation may occur as a discrete stenosis; it can 
also be related to long segment narrowing, hypoplasia 
of the aortic arch, and stenosis of the abdominal aorta, 
and may have collateral vessels [4]. Unrepaired CoA is 
associated with congestive heart failure, aortic rupture, 
infectious endocarditis and intracranial haemorrhage [2] 
and mortality of more than 80% by the age 50 years [3]. 
Currently, several treatment options are available, includ-
ing surgical and transcatheter interventions by balloon 
angioplasty and stenting, with procedure mortality < 1% 
[1]. Despite improving short-term results, survival after 
aortic coarctation repair is decreased, with a survival rate 
of 74% at 30 years of follow-up [1], due to increased arte-
rial stiffness, arterial hypertension, ischaemic heart dis-
ease, atherosclerosis, chronic heart failure, aortic root an-
eurysms and cerebral vascular accidents [5–10]. Despite 
a successful repair of aortic coarctation, which improves 
prognosis and prolongs life, cardiovascular complications 
occur in most convalescents: arterial hypertension in 
32.5% of CoA patients [11], recoarctation of the aorta in 
3–26% [5], ischaemic heart disease in 4.9% [12], aortic 
aneurysms in 26% [5]. 
Aim
The aim of this study was to describe and analyze 
the type and frequency of late complications in adult pa-
tients after coarctation of the aorta repair, and to assess 
their impact on exercise capacity. 
Material and methods
Fifty-eight adult patients after coarctation of aorta 
repair being under control of the Cardiology Institute in 
Krakow, Poland were included in the study. They were 
compared to 30 healthy, age- and sex-matched volun-
teers. All the participants underwent physical examina-
tion, ambulatory blood pressure measurement, transtho-
racic echocardiography, carotid intima-media thickness 
estimation and cardio-pulmonary exercise test. The clin-
ical analysis included: age, body mass index (BMI), body 
surface area (BSA), arm and leg blood pressure measure-
ment. Data about age at surgery, type of operation, oc-
currence of recoarctation, vascular complications (e.g. ar-
terial hypertension, coronary artery disease, stroke) and 
therapy were collected. The patients were included in the 
study if they were aged ≥ 18 years old and clinically sta-
ble for at least 3 months before examination. The exclu-
sion criteria were: acute vascular or inflammatory illness, 
pregnancy, neoplastic disease, physical disability making 
cardiopulmonary exercise test unfeasible (one person 
was excluded due to paraplegia caused by spinal cord 
damage after operation) and mental disorder making 
it impossible to obtain informed consent. Patients with 
coexisting severe congenital heart diseases (e.g. single 
ventricle heart, transposition of the great arteries) were 
excluded to avoid their influence on exercise capacity in 
the cardiopulmonary test. All participants presented in 
the echocardiography preserved systolic function of the 
left ventricle (ejection fraction above 50% by Simpson 
estimation). None of the study group presented an arm-
leg pressure gradient above 20 mm Hg. In the case of 
restenosis in medical history, patients underwent cardi-
ac catheterization before this research and were treat-
ed with percutaneous angioplasty or stent implantation 
with a successful result in hemodynamic measurement. 
All the participants signed informed consent before 
enrolling in the study. The study protocol followed the 
Helsinki Declaration and was approved by the local ethi-
cal committee (license no. 122.6120.27.2016).
24-hour ambulatory blood pressure 
measurement (ABPM)
Twenty-four hour analysis of the arterial blood pres-
sure was conducted using an automatic sphygmomanom-
eter (automatic sphygmomanometr (Spacelabs Health-
care)). The measurement was taken at the right arm 
every 15 min during the day and every 30 min during the 
night (daytime 7 a.m. to 10 p.m., night-time 10 p.m. to 
7 a.m.). The average values of the systolic and diastolic 
pressure were calculated from all scores; the recordings 
were considered when they included more than 80% val-
id measurements. The anti hypertensive therapy (if indi-
cated previously) was continued during the examination. 
Values higher than 135/85 mm Hg during the daytime 
and above 120/70 mm Hg at night-time were considered 
indicative of arterial hypertension [13].
Transthoracic echocardiography (TTE)
All subjects underwent comprehensive transthorac-
ic echocardiography using the Vivid 7 system, General 
Electric Medical Systems, USA with a  2.5 MHz probe 
in 2D, M and Doppler modes. The left ventricle systolic 
(Biplane Simpson method) and diastolic function (Tis-
sue Doppler Imaging) were estimated as well as the left 
ventricle wall thickness and mass, which was indexed 
for body surface area. The concomitant valvular heart 
diseases were acquired. The aortic root diameter and 
a  peak systolic transisthmic gradient were obtained 
from the suprasternal window. According to ESC guide-
lines [13] left ventricular hypertrophy was diagnosed 
if left ventricular mass index (LVMI) was higher than 
115 g/m2 for men and 95 g/m2 for women, while im-
paired systolic left ventricle function was diagnosed 
when ejection fraction measured by the Simpson meth-
od extended below 50%. 
Carotid intima-media thickness (CIMT)
The measurements were obtained from the arteri-
al wall segments of the right and left common carot-
id arteries, carotid bulbs and internal carotid arteries. 
The mean CIMT was defined as the mean CIMT of the 
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near and far walls from both the left and right carotid 
arteries from three measurements [14]. The Vivid 7 sys-
tem, General Electric Medical Systems, USA with 7.5 to 
10 MHz linear probe was used. The examinations were 
conducted by one experienced physician, with no blind-
ed results. 
Cardiopulmonary exercise test (CPET)
The cardiopulmonary exercise test was performed 
to evaluate the exercise tolerance in the symptom 
limited modified Bruce protocol. Oxygen uptake (VO
2), 
carbon dioxide production (VCO
2) and minute ventila-
tion (VE) were measured at rest and peak exercise with 
a computerized analyser. The peak oxygen uptake VO
2/
kg peak (ml/kg/min) determined by the highest value 
of workload, peak heart rate and percentage of maxi-
mal heart rate were assessed. The ventilatory anaero-
bic threshold was calculated by means of the V-slope 
method. The ventilatory equivalent for carbon dioxide 
(VE/VCO
2) was calculated as the amount of ventilation 
needed for the elimination of a given amount of carbon 
dioxide. The respiratory exchange ratio (RER) was as-
sessed by dividing VCO
2 by VO2 [15, 16]. The cardiopul-
monary exercise test was considered as maximal if the 
respiratory quotient (carbon dioxide production divided 
by oxygen consumption) was higher than 1.1, maxi-
mal heart rate higher than 85% of the age predicted 
maximal heart rate or maximal exertion of the patient 
occurred. Exercise capacity was quantified as metabol-
ic equivalents (METs); one metabolic equivalent is the 
amount of oxygen consumed at rest and is equivalent 
to 3.5 ml O
2/kg body × min. The blood pressure was 
measured at rest, every stage during the exercise, at 
peak workload and at recovery. All the anti-hyperten-
sive therapy (including β-blockers) was suspended 48 h 
before the exercise test. 
Statistical analysis
The continuous data were presented by means of the 
average value with the standard deviation or by median 
with the lower and upper quartile in the case of non-nor-
mal distribution of the data. To compare the averages be-
tween three different populations one-way ANOVA was 
performed if all assumptions were met, otherwise the 
Kruskal-Wallis test or Welch test was used. In the case 
of significant results of one of those analyses, a post-hoc 
test was applied. Normality was verified by means of the 
Shapiro-Wilk test, and the Levene test was applied to in-
vestigate heterogeneity of variance. Correlation between 
two continuous variables was assessed based on the 
Pearson or Spearman coefficient. Results with a p-value 
lower than the significance level α = 0.05 were consid-
ered as statistically significant. The calculations were 
performed using the R statistical package version 3.3.1 
(www.r-project.org). 
Results
Fifty-eight adult patients after coarctation of aorta 
repair were included in the study, 36 male, 22 female, 
median age 27.46 ±10.57 years. They were compared to 
30 healthy, age- and sex-matched volunteers. The me-
dian age at coarctation operation time was 8.68 ±8.64 
years, the median follow-up time was 20.39 ±9.8 years. 
The most common type of operation was Dacron/Go-
re-tex patch repair in 25 (43.1%) patients, 18 (31.03%) 
were operated on by Waldhausen subclavian flap an-
gioplasty, 7 (12.06%) by end-to-end anastomosis and 
8 (13.8%) underwent percutaneous angioplasty with stent 
implantation in adolescent or adult age. Fifteen (25.86%) 
were operated on due to concomitant ventricle septal de-
fect (VSD), 6 (12.07%) due to persistent ductus arteriosus 
(PDA), 10 (17.24%) because of hypoplastic aortic arch, 
1 (1.72%) person underwent aortic valve replacement 
(AVR) and 4 (6.89%) Bentall de Bono operation due to aortic 
valve dysfunction and aortic aneurysm. In the CoA group, 
there were 36 (62.06%) people with bicuspid aortic valve. 
Patients with recoarctation (15, 25.86%) in medical histo-
ry were treated at median age 15.5 ±8.17 years. None of 
the observed patients had a blood pressure (BP) difference 
> 20 mm Hg between upper and lower limbs (Table I).
Transthoracic echocardiography and carotid 
intima-media thickness
We revealed that CoA patients in comparison to 
healthy controls have higher echocardiographic parame-
ters: left ventricular mass index (LVMI) 118.09 ±33.28 vs. 
96.41 ±19.99 g/m2, p < 0.001, left ventricle diastolic wall 
thickness: interventricular septum diameter (IVSD) 10.5 
±1.95 vs. 8.9 ±1.06 mm and posterior wall diameter (PWD) 
9.81±1.58 vs. 8.80 ±0.96 mm, p < 0.001 respectively, as-
cending aorta diameter 31.50 ±6.16 vs. 28.03 ±1.79 mm, 
p < 0.001 and impaired diastolic function of the left 
ventricle: E′ velocity 10.05 ±2.66 vs. 11.33 ±2.61 cm/s, 
p = 0.034, E/E’ 10.22 ±5.25 vs. 8.01 ±1.76, p = 0.028 and 
mitral annular plane systolic excursion (MAPSE) 15.03 
±1.65 vs. 15.90 ±1.03 mm, p = 0.011. Intima-media thick-
ness of the carotid arteries was higher in the CoA group, 
0.69 ±0.18 vs. 0.57 ±0.08 mm, p < 0.001 (Table II).
We found no statistically significant differences of the 
left ventricle dimensions and systolic function between 
CoA patients and healthy controls. 
When comparing echocardiographic parameters of 
the CoA cohort with arterial hypertension (28/58) to 
normotensive CoA subjects (30/58) then in hypertensive 
CoA patients these parameters were higher: LVMI 129.84 
±36.79 vs. 107.13 ±25.68 g/m2, p = 0.008, IVSD 11.46 ±1.99 
vs. 9.60 ±1.45 mm, p < 0.001, PWD 10.42 ±1.79 vs. 9.23 
±1.10 mm, p = 0.003, CIMT 0.77 ±0.18 vs. 0.61 ±0.14 mm, 
p < 0.001 and the left ventricle diastolic function was im-
paired in the hypertensive group, E′ mean 9.32 ±3.09 vs. 
10.73 ±2.01 cm/s, p = 0.042, E/E′ 11.53 ±6.91 vs. 8.99 
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±2.57, p = 0.065, MAPSE 15.00 ±2.03 vs. 15.06 ±1.23 mm, 
p = 0.879.
No statistically significant differences in the echo-
cardiography were observed between CoA subjects who 
underwent treatment of re-stenosis (15/58) and the co-
hort without residual coarctation (43/58): LVMI 110.72 
±33.41 vs. 120.67 ±33.24 g/m2, p = 0.323, IVSD 10.66 
±2.44 vs. 10.44 ±1.79 mm, p = 0.705, PWD 9.73 ±1.10 
vs. 9.83 ±1.73, p = 0.829, E′ mean 11.13 ±2.29 vs. 9.67 
±2.70 cm/s, p = 0.067, E/E′ 8.53 ±2.95 vs. 10.80 ±5.76, 
p = 0.152, CIMT 0.71 ±0.16 vs. 0.68 ±0.19 mm, p = 0.561.
Cardiopulmonary exercise test
The results of the cardiopulmonary exercise tests of 
CoA patients in comparison with control group revealed 
statistically significant differences (p < 0.001): VO
2/kg 
AT and VO2/kg peak were significantly lower 20.09 ±6.0 
vs. 36.31 ±10.68 and 29.01 ±8.79 vs. 49.16 ±7.38 ml/kg/
min, p < 0.001 respectively and VE/VCO
2 peak was higher, 
28.18 ±4.69 vs. 26.78 ±3.13, p = 0.017, in CoA patients 
than in the control group. The peak heart rate (HR) and 
the percentage of maximal heart rate were significantly 
reduced in the study group. The peak systolic blood pres-
Table I. Baseline characteristics of study group 
Parameter CoA (n = 58) 
22 F/36 M
CG (n = 30) 
12 F/18 M
P-value
Age [years] 27.46 ±10.57 27.50 ±8.60 0.930
Height [cm] 172.05 ±10.81 174.07 ±8.91 0.383
Weight [kg] 73.21 ±15.06 73.30 ±14.14 0.978
BMI [kg/m2] 23.63 ±12.81 24.49 ±9.90 0.972
BSA [m2] 1.84 ±0.24 1.87 ±0.21 0.562
Age at operation [years] 8.68 ±8.64 N/D N/D
Follow-up [years] 20.39 ±9.8 N/D N/D
Moderate MR (%) 6.89 0 N/D
Severe AS or AR (%) 0 0 N/D
Moderate AS (%) 12.06 0 N/D
Moderate AR (%) 24.14 0 N/D
Bicuspid aortic valve (%) 62.06 0 N/D
Aortic valve replacement (%) 1.72 0 N/D
Aortic aneurysm (%) 0 0 N/D
Aortic dilatation (%) 13.79 0 N/D
Bentall de Bono surgery (%) 6.89 0 N/D
Hypoplastic aortic arch (%) 17.24 0 N/D
Recoarctation (%) 25.86 0 N/D
Arterial hypertension (%) 48.31 0 N/D
Coronary artery intervention (%) 6.89 0 N/D
Cerebral vascular insult (%) 0 0 N/D
β-blocker therapy (%) 53.4 0 N/D
ACE inhibitor therapy (%) 36.2 0 N/D
AT1 blockers (%) 6.9 0 N/D
Ca blockers (%) 17.2 0 N/D
Diuretics therapy (%) 22.4 0 N/D
Statin therapy (%) 34.2 0 N/D
ASA  (%) 6.9 0 N/D
AR – aortic valve, regurgitation, AS – aortic valve stenosis, ASA – acetylsalicylic acid, BMI – body mass index, BSA – body surface area, MR – mitral valve regurgitation. 
Data are presented as means with standard deviation (mean ± SD) or as percentage (%) of total number; p-value ≤ 0.05 is considered as statistically significant.
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sure was higher in the CoA cohort when exercise capacity 
as metabolic equivalents (METs) and duration of exercise 
were lower. Significant correlations between VE/VCO2 and 
duration of CPET the test (r = 0.35, p = 0.007), HR peak 
(r = 0.29, p = 0.022), peak workload (r = 0.51, p < 0.001) 
and peak blood pressure were found (r = 0.29, p = 0.023). 
In the whole CoA group there were no significant correla-
tions between CPET parameters and age, BMI or time 
from surgery (Table III).
In comparison between hypertensive CoA patients 
(28/58) and normotensive CoA patients (30/58), heart rate 
peak was lower, 149.75 ±20.77 vs. 164.30 ±21.52 bpm, 
p = 0.011, and systolic blood pressure peak higher in 
the hypertensive population, 182.93 ±14.70 vs. 167.20 
Table II. Echocardiographic parameters: comparison between coarctation of aorta patients and controls
Parameter Study group (n = 58) Controls (n = 30) P-value
LVD [m] 50.41 ±6.19 48.66 ±4.75 0.180
LVS [mm] 31.26 ±5.17 30.13 ±4.18 0.306
LV EF (%) 66.46 ±6.42 67.16 ±4.76 0.599
LVMI [g/m2] 118.09 ±33.28 96.41 ±19.99 0.0015
IVSD [mm] 10.50 ±1.96 8.90 ±1.06 < 0.001
PWD [mm] 9.81 ±1.58 8.80 ±0.96 0.0019
Ascending aorta [mm] 31.50 ±6.16 28.03 ±1.79 0.003
Maximal gradient at coarctation [mm Hg] 25.86 ±12.96 6.65 ±1.56 < 0.001
E′ mean [cm/s] 10.05 ±2.66 11.33 ±2.61 0.034
E/E′ 10.21 ±5.25 8.01 ±1.76 0.028
MAPSE [mm] 15.03 ±1.65 15.90 ±1.03 0.011
CIMT [mm] 0.69 ±0.18 0.57 ±0.08 < 0.001
CIMT – carotid intima-media thickness, IVSD – interventricular septum diameter in diastole, LV EF – left ventricle ejection fraction, LVD – left ventricle diastolic dimen-
sion, LVMI – left ventricle mass index, LVS – left ventricle systolic dimension, MAPSE – mitral annular plane systolic excursion, PWD – posterior wall diameter in dias-
tole. Data are presented as means with standard deviation (mean ± SD) or as percentage (%) of total number; pvalue ≤ 0.05 is considered as statistically significant.
Table III. Cardiopulmonary exercise test: comparison of coarctation of aorta patients to control group
Parameter Study group (n = 58) Controls (n = 30) P-value
SBP resting [mm Hg] 136.55 ±16.27 123.47 ±10.34 < 0.001
DBP resting [mm Hg] 74.95 ±12.29 74.83 ±6.91 0.955
% AT predicted 65.07 ±18.34 94.57 ±2.79 < 0.001
Time peak [min] 15.28 ±3.21 16.82 ±2.78 0.027
HR peak [bpm] 157.28 ±22.22 177.93 ±23.08 < 0.001
% HR max 78.81 ±14.72 95.17 ±2.96 < 0.001
VO
2
/kg peak [ml/kg/min] 29.01 ±8.79 49.16 ±7.38 < 0.001
% VO
2
/kg predicted 81.91 ±20.81 95.97 ±3.92 < 0.001
RER peak 1.11 ±0.08 1.12 ±0.09 0.415
VE/VCO
2
 peak 28.18 ±4.69 26.78 ±3.13 0.017
BR peak 45.73 ±23.11 41.76 ±16.95 0.414
MET peak 11.03 ±2.72 12.49 ±0.71 0.005
SBP peak [mm Hg] 174.79 ±17.62 153.33 ±4.79 < 0.001
DBP peak [mm Hg] 77.00 ±14.91 80.00 ±0.21 0.275
BR peak – peak breathing reserve, DBP – diastolic blood pressure, HR peak – heart rate peak, % HR max – percentage of maximal heart rate, SBP – systolic blood pres-
sure, RER peak – peak respiratory exchange ratio, VCO
2
 peak – peak carbon dioxide production, VCO
2
 rest – carbon dioxide production at rest, VE/VCO
2
 peak – peak 




/kg AT – oxygen uptake per kg at anaerobic threshold, VO
2
/kg peak – peak oxygen uptake per kg, VO
2
/kg rest – oxygen uptake per 
kg at rest, VO
2
 peak – peak oxygen uptake, VO
2
 rest – oxygen uptake at rest. Data are presented as means with standard deviation (mean ± SD) or as percentage (%) 
of total number; p-value ≤ 0.05 is considered as statistically significant.
Beata Róg et al. Outcomes after aortic coarctation repair 
460 Advances in Interventional Cardiology 2019; 15, 4 (58)
±16.89 mm Hg, p < 0.001. The VO2/kg peak and the per-
centage of predicted value for age were similar in these 
groups: 29.27 ±9.90 vs. 28.76 ±7.77 ml/kg/min, p = 0.828, 
83.86 ±22.19 vs. 80.10 ±19.64%, p = 0.497 respectively. 
There was no statistically significant difference between 
the groups in VE/VCO
2 peak: 24.50 ±3.17 vs. 26.08 ±4.36 
ml/kg/min, p = 0.120, duration of the test: 15.24 ±2.99 
vs. 15.30 ±3.44 min, p = 0.948 and maximal workload: 
11.24 ±2.49 vs. 10.83 ±2.94 MET, p = 0.562 (Table IV). 
No statistically significant differences in the cardio-
pulmonary results were observed between CoA subjects 
who underwent treatment of re-stenosis (15/58) and 
the cohort without residual coarctation (43/58): VO
2/kg 
peak 28.13 ±8.77 vs. 29.31 ±8.87 ml/kg/min, p = 0.656, 
VE/VCO
2 peak 24.31 ±3.20 vs. 25.67 ±4.07 ml/kg/min, 
p = 0.243, maximal workload 11.16 ±2.55 vs. 10.98 
±2.80 MET, p = 0.822, SBP peak 180.33 ±16.95 vs. 172.86 
±17.62 mm Hg, p = 0.159, DBP peak 81.33 ±15.52 vs. 
75.49 ±14.57 mm Hg, p = 0.194 (Table V). 
24-hour ambulatory blood pressure 
measurement
The results of the 24-hour ABPM of CoA patients in 
comparison with the control group revealed statistically 
significant differences: daytime systolic blood pressure 
(SBP) and diastolic blood pressure (DBP) were higher, 
128.13 ±12.47 vs. 106.43 ±6.23 mm Hg and 74.62 ±9.60 
vs. 69.83 ±5.29 mm Hg, p < 0.001 and p = 0.013 respec-
tively; the night values of SBP and DBP were also signifi-
cantly raised in the CoA cohort (112.08 ±13.63 vs. 97.36 
±10.41 mm Hg and 62.91 ±9.17 vs. 59.03 ±8.28 mm Hg, 
p < 0.001 and p = 0.026 respectively. 
When analysing ABPM results in the hypertensive 
CoA cohort in comparison to the normotensive CoA co-
hort, the SBP during the day and the night time were 
higher in the first group, 134.46 ±10.36 vs. 122.23 ±11.45 
mm Hg and 118.60 ±12.28 vs. 106.03 ±12.06 mm Hg, 
p < 0.001; no other statistically significant differences be-
tween these groups were exposed in ABPM.
In comparison of ABPM measurements in CoA sub-
jects who underwent treatment of re-stenosis (15/58) 
and the cohort without residual coarctation (43/58) 
there were no statistically significant differences in SBP 
and DBP values during the day and night time between 
the groups. 
In the whole CoA group, we revealed a  statistically 
significant correlation of systolic blood pressure in ABPM 
with: left ventricle mass index (r = 0.29, p = 0.025) and 
Table IV. Comparison of hypertensive to normotensive coarctation of aorta patients
Parameter H CoA (n = 28) N CG (n = 30) P-value
Age [years] 33.50 ±12.23 25.73 ±7.12 0.004
Age at operation [years] 10.57 ±14.89 6.76 ±9.34 0.245
Follow-up [years] 22.07 ±11.56 18.96 ±7.78 0.232
Hypoplastic aortic arch (%) 28.57 6.66 0.027
Recoarctation (%) 39.28 13.33 0.024
HR peak [bpm] 149.75 ±20.77 164.30 ±21.52 0.011
% HR max 75.21 ±13.50 82.17 ±15.22 0.071
VO
2
/kg peak [ml/kg/min] 29.27 ±9.90 28.76 ±7.77 0.828
% VO
2
/kg peak predicted 83.86 ±22.19 80.10 ±19.64 0.497
VE/VCO
2
 peak 24.50 ±3.17 26.08 ±4.36 0.120
SBP peak [mm Hg] 182.93 ±14.70 167.20 ±16.89 < 0.001
DBP peak [mm Hg] 80.82 ±15.19 73.43 ±13.96 0.058
LVMI [g/m2] 129.84 ±36.79 107.13 ±25.68 0.008
IVSD [mm] 11.46 ±1.99 9.60 ±1.45 < 0.001
PWD [mm] 10.42 ±1.79 9.23 ±1.10 0.003
E′ mean [cm/s] 9.32 ±3.09 10.73 ±2.01 0.042
E/E′ 11.53 ±6.91 8.99 ±2.57 0.065
CIMT [mm] 0.77 ±0.18 0.61 ±0.14 < 0.001
CIMT – carotid intima-media thickness, DBP – diastolic blood pressure, HR peak – heart rate peak, % HR max – percentage of maximal heart rate, IVSD – interven-
tricular septum diameter in diastole, LVMI – left ventricle mass index, PWD – posterior wall diameter in diastole, SBP – systolic blood pressure, VE/VCO
2
 peak – peak 




/kg peak – peak oxygen uptake per kg, VO
2
/kg rest – oxygen uptake per kg at rest, VO
2
 peak – peak oxygen uptake. Data are 
presented as means with standard deviation (mean +SD) or as percentage (%) of total number; p-value ≤ 0.05 is considered as statistically significant.
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wall thickness (r = 0.31, p = 0.039). Older age at opera-
tion was related to left ventricle walls thickness (r = 0.27, 
p = 0.041) and carotid intima-media thickness (r = 0.26, 
p = 0.046). Statistical analysis showed no association of 
any cardio-pulmonary parameters with time from sur-
gery, type of operation or echocardiography results.
Discussion 
The principal finding in the present study is that in 
patients after aortic coarctation repair despite successful 
short-term outcomes late cardiovascular complications 
occur. 
The main comorbidity after successful repair of aortic 
coarctation is arterial hypertension, present in 48.3% of 
subjects in our study, which is compatible with literature 
data, 32.5% (range: 25–68%) [11]. Hypertensive patients 
in our study were older. Many of them were treated due 
to recoarctation and suffered from hypoplastic aor-
tic arch. Patients with arterial hypertension presented 
higher mass of the left ventricle, greater wall thickness 
and greater carotid intima-media thickness. They had 
impaired left ventricle diastolic function. These chang-
es are common in patients with arterial hypertension 
and widely described in the literature [17–20]. Causes 
of arterial hypertension in coarctation of aorta patients 
are multifactorial. The aorta wall, in the section before 
the narrowing, has a different structure, contains more 
collagen and less elastin fibre, and lacks smooth muscle 
cells. The aortic wall stiffness is increased [9], sensitiv-
ity reduced and the aorta mechanoreceptors activated. 
The pathophysiological processes are initiated with an 
advantage of the sympathetic system, changes in the en-
docrine system, endothelial dysfunction and remodelling 
of the vessels, which leads to increase of the peripheral 
vascular resistance and increase in blood pressure [20]. 
Data from the literature [21] indicate that among con-
genital heart diseases arterial hypertension is the most 
frequent in coarctation of the aorta. The discussion about 
conditions of coarctation repair (time of intervention and 
type of operation) to avoid arterial hypertension is still 
open. In our study patients with arterial hypertension 
were older and operated on at older age than normoten-
sive subjects. The observations from other studies [22] 
reveal that younger age at operation is related to lower 
arterial pressure at follow-up; it is the best if treatment 
is applied before 9–10 years old. We did not observe the 
Table V. Comparison of recoarctation to no-recoarctation of aorta patients
Parameter Re CoA (n = 15) NoRe CoA (n = 43) P-value
Age [years] 26.26 ±6.34 29.93 ±11.12 0.233
Age at operation [years] 5.80 ±5.87 9.58 ±13.87 0.312
Follow-up [years] 20.73 ±9.41 20.37 ±10.07 0.903
Hypoplastic aortic arch (%) 46.66 6.97 < 0.001
Arterial hypertension (%) 73.33 39.53 < 0.001
HR peak [bpm] 62.93 ±15.25 65.81 ±19.40 0.604
% HR max 71.93 ±14.51 81.21 ±14.17 0.034
VO
2
/kg peak [ml/kg/min] 28.13 ±8.77 29.31 ±8.87 0.656
% VO
2
/kg peak predicted 77.47 ±19.85 83.46 ±21.14 0.341
VE/VCO
2
 peak 24.31 ±3.20 25.67 ±4.07 0.243
SBP peak [mm Hg] 180.33 ±16.95 172.86 ±17.62 0.159
DBP peak [mm Hg] 81.33 ±15.52 75.49 ±14.57 0.194
LVMI [g/m2] 110.72 ±33.41 120.67 ±33.24 0.323
IVSD [mm] 10.66 ±2.44 10.44 ±1.79 0.705
PWD [mm] 9.73 ±1.10 9.83 ±1.73 0.829
E′ mean [cm/s] 11.13 ±2.29 9.67 ±2.70 0.067
E/E′ 8.53 ±2.95 10.80 ±5.76 0.152
CIMT [mm] 0.71 ±0.16 0.68 ±0.19 0.561
CIMT – carotid intima-media thickness, DBP – diastolic blood pressure, HR peak – heart rate peak, % HR max – percentage of maximal heart rate, IVSD – interven-
tricular septum diameter in diastole, LVMI – left ventricle mass index, PWD – posterior wall diameter in diastole, SBP – systolic blood pressure, VE/VCO
2
 peak – peak 




/kg peak – peak oxygen uptake per kg, VO
2
/kg rest – oxygen uptake per kg at rest, VO
2
 peak – peak oxygen uptake. Data are 
presented as means with standard deviation (mean ± SD) or as percentage (%) of total number; p-value ≤ 0.05 is considered as statistically significant.
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influence of type of surgery on development of arterial 
hypertension. The opposite conclusion was presented by 
Giordano et al. [23] – patients after subclavian flap sur-
gery in comparison to end-to-end anastomosis showed 
a higher incidence of hypertension. The authors explain 
that fact by greater resection of the abnormal aortic tis-
sue in the second method and lower aortic stiffness as 
a consequence. Our observations from cardiopulmonary 
exercise tests revealed that raised initial arterial pressure 
in the exercise test is a marker of hypertensive disease in 
CoA subjects. All hypertensive patients presented higher 
values of the resting arterial pressure in CPET than nor-
motensive ones. On the other hand, only 5 out of 58 pa-
tients (8.62%) reached values above 200/110 mm Hg at 
peak workload, which was considered as a hypertensive 
reaction to exercise test. All of them were treated due to 
arterial hypertension before. Many authors [24–30] have 
analysed arterial pressure reaction on effort during the 
exercise tests. The main conclusions are that elevated 
arterial pressure at the beginning of the test and hyper-
tensive reaction at peak exercise are the symptoms of 
arterial hypertension in longer follow-up. 
In the present research, the cardiopulmonary exercise 
tests of CoA patients in comparison to controls revealed 
lower values of: VO
2/kg peak, heart rate peak, % max 
HR, exercise capacity as metabolic equivalents and du-
ration of an exercise. The reason for these results is still 
uncertain. There may be some influence of chronotrop-
ic incompetence, which occurred in 27.58% of subjects 
if described as maximal heart rate percent below 80% 
at peak workload. β-blocker therapy was suspended 
48 h before to avoid its impact on heart rate. Data from 
the literature [31, 32] indicate that chronotropic incom-
petence in adults after a congenital heart disease oper-
ation was related to lower VO
2/kg peak and higher risk 
of cardiac insufficiency in future. We revealed significant 
correlations between VE/VCO
2 and duration of CPET, 
HR peak, peak workload (METs) and peak blood pressure. 
No other associations were found. 
In our study all patients with restenosis (25.86%) 
underwent cardiac catheterization before this research 
and were treated with percutaneous angioplasty or stent 
implantation with a  successful result in hemodynamic 
measurement. Most of them, despite the effective inter-
vention, suffered from arterial hypertension. Data from 
the literature [33–40] demonstrate a  decrease of arte-
rial pressure after percutaneous intervention, although 
still higher values than in the healthy population. In our 
observation, patients with aortic recoarctation had more 
often concomitant hypoplastic aortic arch. Age at oper-
ation and length of follow-up had no impact on aortic 
restenosis occurrence. We did not observe statistically 
significant differences between any of the echocardiog-
raphy or cardiopulmonary test results between patients 
with recoarctation and the no-recoarctation ones. In case 
of recurrent significant coarctation of the aorta, invasive 
treatment is recommended as soon as possible, with 
modification of hypotensive therapy if needed [41].
A significant comorbidity among CoA patients is aor-
tic aneurysm formation. This process is related to disor-
ders of thoracic aorta wall structure and impaired me-
chanical function of aortic tissue. Arterial hypertension, 
which is common in this population, additionally has 
a positive impact on rise in tension of the aortic walls. 
More frequent aortic aneurysm development is observed 
in patients with coexisting bicuspid aortic valve, which 
can be explained by a general vascular disorder of the 
thoracic aorta in both groups. In our research we did not 
observe aortic aneurysm of any patients, but 6.89% of 
our CoA patients had undergone a Bentall de Bono oper-
ation. Furthermore, ascending aorta diameter was higher 
in the CoA group than in controls and 13.79% of CoA sub-
jects had ascending aorta dilatation. All the cases were 
related to presence of bicuspid aortic valve. We did not 
reveal any association between ascending aorta diame-
ter and type of aortic coarctation surgery. Data from the 
literature [42–44] show that aneurysms are more com-
mon after patch aortoplasty technique and transcatheter 
interventions, particularly balloon angioplasty without 
stent implantation. 
A  significant comorbidity after successful aortic 
coarctation repair is premature atherosclerosis. In our 
observations 6.89% of patients had confirmed coronary 
artery disease in angiography. These patients were older 
than the others from the CoA group, were operated on 
due to CoA in older age (after 18 years old) and suffered 
from concomitant cardio-vascular risk factors (e.g. hyper-
lipidemia, obesity and diabetes mellitus). Other authors 
have reported [7, 45] that coarctation of aorta does not 
increase risk of coronary artery disease itself, but due to 
concomitant arterial hypertension and endothelial dys-
function. Strict control of conventional atherosclerosis 
risk factors after coarctation repair reduces long-tem 
vascular risk. 
Study limitations
Several limitations of the study should be acknowl-
edged. First, the number of patients in the study was 
small. It is representative for a patient population in re-
al-life clinical practice, but a larger study group is expect-
ed. Second, the hypertensive patients in our study were 
under treatment such as ACE inhibitors and β-blockers, 
drugs that have an influence on cardio-pulmonary test 
results. The therapy was suspended 48 h before the ex-
amination to reduce its impact on measurement results. 
Certainly, longer follow-up is required; some comorbidi-
ties may occur at a later time. 
Conclusions
Despite successful aortic coarctation repair and pos-
itive short-term outcomes, adult patients in longer fol-
Beata Róg et al. Outcomes after aortic coarctation repair 
463Advances in Interventional Cardiology 2019; 15, 4 (58)
low-up are exposed to arterial hypertension, vascular 
complications such as recurrent aortic stenosis, aneu-
rysms formation and premature atherosclerosis. They 
have reduced exercise capacity, which is related to hy-
pertensive reaction, increased arterial stiffness and chro-
notropic incompetence. Exercise intolerance occurs as 
a result of lowered oxygen uptake and increased venti-
latory response. These patients require regular follow-up 
to reduce long-term morbidity and mortality after coarc-
tation repair. 
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